Entacapone Tablet
Product Images NDC 27241-049

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Entacapone (NDC 27241-049). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ajanta Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Enta Structure)

FDA Label Image

Entacapone-200mg (Entacapone 200mg)

Entacapone-200mg (Entacapone 200mg)
Entacapone Tablets, USP are indicated for the treatment of Parkinson's disease. The tablets come in 200 mg with a supply of 100 tablets. The package is child-resistant and should be stored in light-resistant containers at 25°C (77°F); excursions to the Controlled Room Temperature are allowed. The usual adult dosage is mentioned in the package insert for dosage information. The tablets are marketed by Ajanta Pharma USA Inc. and made in India. The product is identified by the NDC code 27241-049-10, and the code number MH/DRUGS/AD/018.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.